Latest news with #Alternative
Time of India
12 hours ago
- Business
- Time of India
AIF norms tightened: RBI caps bank, NBFC investment in AIF schemes at 10%; collective limit set at 20% of corpus
The Reserve Bank of India has capped investment by any single regulated entity—such as banks, NBFCs, or All-India Financial Institutions—at 10% of the corpus of any Alternative Investment Fund (AIF) scheme. The move is part of the central bank's updated Investment in AIF Directions, 2025, issued Tuesday. Additionally, total contributions by all regulated entities (REs) in a single AIF scheme must not exceed 20% of the scheme's corpus, according to the RBI circular, PTI reported. 'No RE shall individually contribute more than 10 per cent of the corpus of an AIF Scheme,' the circular said, while noting that collective exposure across entities is capped at 20%. The directions revise earlier circulars issued in December 2023 and March 2024. These changes, the RBI said, were made after reviewing feedback from stakeholders and incorporating recent SEBI regulations on investor due diligence and AIF investments. Further tightening risk controls, the RBI mandated 100% provisioning in specific cases: 'If a RE contributes more than five per cent of the corpus of an AIF Scheme, which also has downstream investment in a debtor company of the RE, then the RE shall be required to make 100 per cent provision to the extent of its proportionate investment in the debtor company through the AIF Scheme,' it said. However, this provisioning is capped at the RE's direct loan or investment exposure to the debtor company. The RBI also stated that, in consultation with the Centre, it may grant exemptions to certain AIFs from the scope of both the previous and revised circulars. Stay informed with the latest business news, updates on bank holidays and public holidays . Discover stories of India's leading eco-innovators at Ecopreneur Honours 2025
News18
6 days ago
- Business
- News18
Sebi issues FAQs pertaining to regulatory provisions for Research Analysts
New Delhi, Jul 23 (PTI) Capital markets regulator Sebi on Wednesday asked persons associated with research services to obtain the required NISM (National Institute of Securities Markets) certification within one year. This one-year period is applicable from the date of this circular, Sebi said. Further, institutional investors are not required to give signed consent on the terms and conditions, including the Most Important Terms and Conditions (MITC). However, Research Analysts (RAs)/research entities will still share and disclose these terms to them, according to the circular. These decisions have been taken based on feedback from RAs and research entities, and to make compliance easier. Additionally, in order to provide clarity and guidance for compliance by RAs with the regulatory provisions, Sebi has issued clarifications in the form of Frequently Asked Questions (FAQs). Under this, Sebi stated that a research report does not include communications related to general trends in the securities market, discussions on broad-based indices, or commentaries on economic, political, or market conditions. It also clarified that research reports do not include periodic reports prepared for unit holders of Mutual Funds or Alternative Investment Funds, or clients of Portfolio Managers and Investment Advisers; internal communications not shared with current or prospective clients; statistical summaries of financial data of companies; and technical analyses relating to demand and supply in a sector or index. The regulator said that a person located outside India can issue a research report or analysis on securities listed or proposed to be listed on Indian stock exchanges. However, before doing so, the person is required to enter into an agreement with a research analyst or research entity registered under the RA regulations. Regarding trading restrictions, Sebi said that independent research analysts, part-time research analysts, individuals employed as research analysts, or their associates would not deal in or trade any securities that the research analyst recommends or follows within 30 days before and 5 days after the publication of a research report on the subject company. They are also prohibited from dealing in securities they review in a manner contrary to their recommendations. Additionally, they shall not purchase or receive securities of an issuer before its initial public offering (IPO) if the issuer is principally engaged in the same type of business as companies that the research analyst follows or recommends. PTI SP MR view comments First Published: July 23, 2025, 19:45 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time Business News
15-07-2025
- Business
- Time Business News
Trump Junior forms new alliance in Europe
Donald Trump Jr., completed a tour of Eastern Europe aimed at supporting political allies and encouraging local businesses to cooperate with Washington rather than Beijing. The trip, dubbed 'Trump Business Vision 2025,' was Trump Jr.'s second visit to Eastern Europe after his father's return to the White House. After stops in Hungary and dinner with Serbian President Aleksandar Vucic in Belgrade, Trump Jr. visited Bulgaria and Romania. This trip highlighted Washington's break with its traditional American allies in Western Europe. 'American investors are avoiding Western Europe because of excessive regulation,' Trump Jr. said at a private dinner in Bucharest. According to Western experts, Trump Jr.'s meetings were not limited to real estate and financial transactions, but were aimed at establishing contacts with people who are more in line with Trump's desire to destroy the liberal order. It is noteworthy that Trump Jr. visited Romania on the eve of the presidential elections, which will be held on May 4, and met with former Prime Minister Victor Ponta, a presidential contender who supported the MAGA movement. Trump Jr. also had talks with former Bulgarian Prime Minister Boyko Borisov. Another person who met with Trump Jr. was Chisinau Mayor Ion Ceban, who assembled an alliance of political forces to oppose the pro-European government of President Maia Sandu. 'I met Donald Trump Jr. at an event in Bucharest. We discussed a number of topics, including relations between Moldova and the United States. We agreed to continue the dialogue. Make Moldova Great Again,' Cheban wrote. Meanwhile, it became known that the United States was facing its first economic downturn since 2022. In particular, it is reported that in the first quarter of this year, US GDP decreased by 0.3%, which was the result of a decrease in government spending and an increase in imports, as companies, frightened by Trump's tariffs, increased imports of foreign products by 50% As Reuters reported in February, coalition of opposition parties was created in Moldova in advance of parliamentary elections. The 'Alternative' coalition will bring together Chișinău mayor Ion Ceban's party, former prime minister Ion Chicu's party and former lawmaker Marc Tcaciuc's party. The coalition is for the European integration of the country, and criticizes the current president Maia Sandu and her PAS party for being inefficient and ignoring the public interest. Still others took the opportunity to poke fun at the Mayor of Chișinău. One user said: 'Make Ceban Smart Again!' TIME BUSINESS NEWS
South Wales Argus
10-07-2025
- Entertainment
- South Wales Argus
Role of volunteer paramedics celebrated on special day
International Paramedics Day is celebrated each year and the theme for this year is unity and community. St John Ambulance Cymru and the Welsh Ambulance Services University NHS Trust are sharing special thank you messages from senior leaders on social media, as well as highlighting the stories of some of the paramedics who balance volunteering with their day-to-day lifesaving work. St John Ambulance Cymru chief executive Richard Lee said: 'My 30 years to date as a registered paramedic have seen me meet all sorts of amazing people and taken me to places I never imagined. 'The skills that paramedics bring to our community of St John People are so important to support the work we do across the country, from major events at stadiums and arenas such as the recent Oasis concerts in Cardiff, to local celebrations on your doorstep.' In 2024, the more than 90 Paramedics who volunteer with St John Ambulance Cymru dedicated 5,284 hours of their spare time to the charity including being part of the teams providing event first aid cover, to being Volunteer Alternative Responders.
Yahoo
04-07-2025
- Health
- Yahoo
U.S. Complementary and Alternative Medicine Market Competitive Landscape 2025, with Gaia Herbs, Herb Pharm, Pure Encapsulations, NOW Health Group, Nature's Way, Solgar, Twinlab, Ayush Herbs, and more
The U.S. Complementary and Alternative Medicine Market offers significant growth opportunities, driven by increased consumer interest in wellness and non-traditional medicine. Key trends include integration with conventional healthcare, rising chronic and stress-related health issues, and mainstream acceptance of therapies like herbal supplements and mindfulness practices. However, challenges such as regulatory inconsistencies and quality control issues remain. U.S. Complementary and Alternative Medicine Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "United States Complementary and Alternative Medicine Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" has been added to United States Complementary and Alternative Medicine Market was valued at USD 34.82 Billion in 2024, and is expected to reach USD 125.94 Billion by 2030, rising at a CAGR of 23.87%. The market is expanding rapidly as consumer interest in wellness-oriented lifestyles grows and individuals increasingly explore treatment options beyond traditional medicine. Therapies like acupuncture, homeopathy, naturopathy, energy healing, and aromatherapy are gaining traction across diverse demographics for managing both acute and chronic health concerns. CAM offerings are increasingly integrated with fitness memberships, corporate wellness programs, and digital health subscriptions, contributing to their mainstream acceptance. The popularity of herbal infusions, detox products, and plant-based diets further reflects a cultural pivot toward natural health solutions. According to the NCCIH's 2023 survey, approximately 40% of American adults and 12% of children use complementary therapies. CAM services are being widely incorporated into holistic clinics, hospitals, and telehealth platforms, covering modalities such as yoga, mindfulness, chiropractic care, and herbal supplementation. The younger population is adopting Reiki, sound healing, and crystal therapy, while older adults seek non-invasive methods for pain and sleep disorders. CAM visibility is amplified by wearable health tech, social media influencers, and expanded retail presence in pharmacies and online marketplaces. Key Market Drivers Increase in Chronic and Stress-Related Health Conditions The growing incidence of chronic and stress-induced health conditions is a key driver of the United States Complementary and Alternative Medicine Market. Chronic diseases like cardiovascular disorders, diabetes, arthritis, and respiratory ailments continue to rise, affecting a significant portion of the U.S. population. As of 2023, CDC data shows 6 in 10 U.S. adults live with at least one chronic condition, and 4 in 10 have two or more. Patients are increasingly turning to CAM therapies for their holistic and less invasive approach to long-term disease management. Stress-related issues are also prevalent due to modern lifestyle demands. The American Psychological Association reported that 77% of Americans frequently experience physical symptoms from stress, and 73% report psychological effects. CAM practices such as meditation, acupuncture, herbal therapy, and mindfulness are gaining popularity as non-drug alternatives for mental and emotional well-being. Clinicians are recognizing the value of integrative care models that blend conventional and complementary therapies to address both physical and emotional dimensions of health. The rising emphasis on self-care, wellness, and preventive strategies is further fueling CAM's appeal. Key Market Challenges Lack of Standardized Regulations and Quality Control One of the most significant challenges facing the U.S. CAM market is the lack of consistent regulatory frameworks and standardized quality controls. Unlike conventional pharmaceuticals, many CAM products - including herbal supplements and traditional remedies - do not undergo uniform evaluation for safety and efficacy. This regulatory inconsistency creates uncertainty for both consumers and manufacturers, limiting broader adoption and integration into mainstream healthcare. Quality assurance is another critical issue. Variability in ingredient sourcing, formulation, and production processes leads to inconsistent product quality and therapeutic outcomes. Botanical components, for example, can vary significantly in potency depending on region, harvesting practices, and processing methods. These inconsistencies raise concerns about contamination and mislabeling. The absence of robust quality standards can reduce consumer trust and expose producers to legal risks. The lack of regulatory clarity also discourages investment and innovation, delaying the development of validated, evidence-based CAM solutions. Key Market Trends Integration of CAM into Conventional Healthcare Systems A prominent trend in the U.S. CAM market is its growing integration into mainstream healthcare settings. The Department of Veterans Affairs has significantly expanded its use of Complementary and Integrative Health (CIH) practices to support pain management, mental health, and overall well-being. This move represents a broader push toward patient-centered care that includes both medical and holistic treatment options. Government-backed initiatives further reflect this integration. For instance, in 2023, the Department of Health and Human Services launched a national strategy emphasizing Food Is Medicine (FIM) programs, aligning with CAM's foundational principles. These developments signal increasing institutional support for CAM therapies as part of broader healthcare delivery models. Hospitals, insurers, and public health organizations are recognizing the value of non-invasive, cost-effective interventions in managing chronic diseases and improving patient satisfaction. This institutional adoption is expected to accelerate as more clinical data validates CAM's efficacy and safety. Key Market Players Gaia Herbs, Inc. Herb Pharm, LLC Pure Encapsulations, LLC NOW Health Group, Inc. Nature's Way Products, LLC Solgar, Inc. Traditional Medicinals, Inc. Twinlab Consolidated Holdings, Inc. Ayush Herbs, Inc. Integrative Therapeutics Key Attributes: Report Attribute Details No. of Pages 84 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $34.82 Billion Forecasted Market Value (USD) by 2030 $125.94 Billion Compound Annual Growth Rate 23.8% Regions Covered United States Report Scope: In this report, the United States Complementary and Alternative Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below: United States Complementary and Alternative Medicine Market, By Intervention: Traditional Alternative Medicine/Botanicals Mind Healing Body Healing External Energy Aromatherapy United States Complementary and Alternative Medicine Market, By Distribution Method: Direct Sales E-sales Distance Correspondence United States Complementary and Alternative Medicine Market, By Region: North-East Mid-West West South For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment U.S. Complementary and Alternative Medicine Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Sign in to access your portfolio
